Contact the Editorial Desk

Editorial correspondence

Correspondence on the research record is welcome: a citation quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study on Semax, Selank, or DSIP that should be added to the references page. Corrections that improve accuracy are the most useful messages this companion receives, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets a proposed change be checked against the source without ambiguity.

Editorial mailbox: editors@peptidefriend.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this companion can address. Peptide Friend reads the literature; it is not a clinic or a vendor, so it cannot:

• Advise on, recommend, or comment on human use of any compound covered here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or assess whether a research finding applies to a particular person's situation.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer athletes under anti-doping rules about using these compounds, given the regulatory uncertainties around non-approved substances.

Anyone seeking guidance on anxiety, cognitive impairment, or sleep disorders should consult a licensed clinician in their own jurisdiction. Replies to editorial correspondence are not guaranteed and may be delayed; the mailbox is watched intermittently.